PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

227 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
41.
Kirstein, A. ; Schilling, D. ; Combs, S.E. & Schmid, T.E.: Influence of MGMT expression on the radiation sensitivity of human glioblastoma cell lines. Strahlenther. Onkol. 196, 1, S185-S185 (2020)
42.
Kraus, K.M.* ; Oechsner, M.* ; Wilkens, J.J. & Combs, S.E.: Stereotactic Irradiation of peripheral Lung Tumors using Respiratory Gating: Correlation between PTV Reduction, Tumor Movement and Volume Dose. Strahlenther. Onkol. 196, 1, S13-S13 (2020)
43.
Kurrumeli, D.* et al.: An easy way to determine bone mineral density and predict pelvic insufficiency fractures in patients treated with radiotherapy for cervical cancer. Strahlenther. Onkol. 197, 487-493 (2020)
44.
Lang, D.M. et al.: Soft tissue sarcoma contouring based on planning CTs using deep learning. Strahlenther. Onkol. 196, 1, S33-S33 (2020)
45.
Maier, S.H.* et al.: Combination of EGFR-specific, 5-FU-bearing Aptamers with Radiation: Characterization in in vitro Models of Squamous Cell Carcinoma of the Head and Neck Region (HNSCC). Strahlenther. Onkol. 196, 1, S188-S188 (2020)
46.
Matuschek, C.* et al.: Measures of infection prevention and incidence of SARS-CoV-2 infections in cancer patients undergoing radiotherapy in Germany, Austria and Switzerland. Strahlenther. Onkol. 196, 1068-1079 (2020)
47.
Muench, S.* ; Devecka, M.* ; Oechsner, M.* ; Friess, H.* & Combs, S.E.: Combined neoadjuvant/definitive Chemoradiotherapy in Patients with Oesophageal carcinoma and irresectable Lymph Node Metastases. Strahlenther. Onkol. 196, 1, S152-S152 (2020)
48.
Münch, S.* et al.: Impact of F-18-FDG-PET/CT on the identification of regional lymph node metastases and delineation of the primary tumor in esophageal squamous cell carcinoma patients. Strahlenther. Onkol. 196, 787-794 (2020)
49.
Mutlu, S.* et al.: Intrinsic radioresistance and intra-tumoral heterogeneity in HNSCC. Strahlenther. Onkol. 196, 1, S189-S190 (2020)
50.
Peeken, J.C. et al.: Development and Validation of a CT-based Radiomic Model for the Detection of Lymph Node Metastases in Patients with recurrent Prostate Cancer. Strahlenther. Onkol. 196, 1, S28-S29 (2020)
51.
Peeken, J.C. et al.: Improved survival prediction in patients with soft tissue sarcoma through the application of deep learning. Strahlenther. Onkol. 196, 1, S33-S34 (2020)
52.
Rödel, F.* et al.: Low-dose radiation therapy for COVID-19 pneumopathy: What is the evidence? Strahlenther. Onkol. 196, 679-682 (2020)
53.
Sage, E.K.* et al.: Stereotactic Body Radiotherapy (SBRT) for the Treatment of oligometastatic Prostate Carcinoma. Strahlenther. Onkol. 196, 1, S160-S161 (2020)
54.
Salfelder, M.A.* et al.: Prospective evaluation of multitarget treatment of pediatric patients with helical intensity-modulated radiotherapy. Strahlenther. Onkol. 196, 1103–1115 (2020)
55.
Schmid, T.E. et al.: Proton minibeam radiation therapy-an innovative strategy in cancer treatment. Strahlenther. Onkol. 196, S109-S109 (2020)
56.
Schmidt-Hegemann, N.-S.* et al.: DNA copy number and DNA methylome analysis of primary prostate cancer and pathologic lymph node metastases in patients with low and high Gleason score. Strahlenther. Onkol. 196, 1, S158-S159 (2020)
57.
Schrickel, F. et al.: Heterogeneous invasion capacity of patient-derived primary glioblastoma multiforme cells. Strahlenther. Onkol. 196, 1, S109-S110 (2020)
58.
Vogel, M.M. et al.: Toxicity of PSMA-PET-based Salvage Radiotherapy with a simultaneous integrated Boost for Patients with Recurrence of Prostate Cancer after radical Prostatectomy. Strahlenther. Onkol. 196, S160-S160 (2020)
59.
Waltenberger, M.* ; Kessel, K.A. ; Devecka, M.* ; Peeken, J.C. & Combs, S.E.: Stereotactic body radiation therapy of spine metastases using a simultaneous integrated boost concept-evaluation of effectiveness and toxicity. Strahlenther. Onkol. 196, 1, S16-S16 (2020)
60.
Al Bazaz, M.* ; Selmansberger, M. ; Engenhart-Cabillic, R.* ; Lauber, K.* & Schoetz, U.*: Tumor stem cell factor CD44v6 influences G2 arrest and radiation sensitivity in S phase after irradiation. Strahlenther. Onkol. 195, S127-S127 (2019)